Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

3537.25 (Glytoucan)

Id:2accc723-47de-516d-b5da-b930a52a5472

Glytoucan:G77687SU

Results found

Linked to

	Label	Description
	3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G85750HN-GLYCOSEQ00092504 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G46260CP-GLYCOSEQ00185227 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3537.25 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3537.25 has canonical residue n-glycan a-d-neupnac 16 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G74018VM-GLYCOSEQ00097471 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G46260CP-GLYCOSEQ00185231 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G73111YU-GLYCOSEQ00005610 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3537.25 has canonical residue n-glycan b-d-galp 3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G73161ZQ-GLYCOSEQ00092936 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G05441GN-GLYCOSEQ00130445 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G85750HN-GLYCOSEQ00092504 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G46260CP-GLYCOSEQ00185227 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3537.25 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3537.25 has canonical residue n-glycan a-d-neupnac 16

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G74018VM-GLYCOSEQ00097471 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G46260CP-GLYCOSEQ00185231 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G73111YU-GLYCOSEQ00005610 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3537.25 has canonical residue n-glycan b-d-galp 3

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G73161ZQ-GLYCOSEQ00092936 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3537.25 has glycosequence GLYGEN.GLYCOSEQUENCE:G05441GN-GLYCOSEQ00130445 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.